CELURAL Trademark

Trademark Overview

On Friday, November 18, 2011, a trademark application was filed for CELURAL with the United States Patent and Trademark Office. The USPTO has given the CELURAL trademark a serial number of 85476711. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2016. This trademark is owned by Eli Lilly and Company. The CELURAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical prepa...
celural

General Information

Serial Number85476711
Word MarkCELURAL
Filing DateFriday, November 18, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 28, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, July 25, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 25, 2016ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 25, 2015EXTENSION 5 GRANTED
Thursday, September 17, 2015EXTENSION 5 FILED
Thursday, September 17, 2015TEAS EXTENSION RECEIVED
Thursday, June 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 10, 2015EXTENSION 4 GRANTED
Friday, May 22, 2015EXTENSION 4 FILED
Friday, May 22, 2015TEAS EXTENSION RECEIVED
Tuesday, December 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 22, 2014EXTENSION 3 GRANTED
Friday, December 12, 2014EXTENSION 3 FILED
Friday, December 12, 2014TEAS EXTENSION RECEIVED
Friday, June 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 12, 2014EXTENSION 2 GRANTED
Tuesday, June 10, 2014EXTENSION 2 FILED
Tuesday, June 10, 2014TEAS EXTENSION RECEIVED
Wednesday, February 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2014EXTENSION 1 GRANTED
Tuesday, December 3, 2013EXTENSION 1 FILED
Friday, January 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 3, 2013TEAS EXTENSION RECEIVED
Tuesday, June 18, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 20, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 19, 2013ASSIGNED TO LIE
Thursday, March 7, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 19, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 19, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 19, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 19, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 19, 2012FINAL REFUSAL E-MAILED
Wednesday, September 19, 2012FINAL REFUSAL WRITTEN
Friday, August 31, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 31, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 31, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 15, 2012NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, March 15, 2012PRIORITY ACTION E-MAILED
Thursday, March 15, 2012PRIORITY ACTION WRITTEN
Tuesday, March 6, 2012ASSIGNED TO EXAMINER
Monday, November 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 22, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

celural disorders diseases pharmaceutical system preparations metabolic migraines liver inflammation gastrointestinal